This study evaluated flurbiprofen-induced alterations of the gastric mucosa in 9 patients suffering from various rheumatic diseases.All patients were given a daily 300 mg dose orally, divided in three parts, the treatment being 2,3 and 4 weeks.Before and after treatment, patients were submitted to radiologic and gastroduodenal examinations, as well as oesophagogastroduodenoscopy and biopsies were taken from the antrum and the fundus of the stomach. Biopsy material was studied by light microscopy.We concluded that this drug was welltolerated and not responsible for significant alterations of the gastric mucosa.